Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN-Reference-Cited by-同舟云学术

Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN

Published:2018-07-08 Issue:5 Volume:48 Page:523-537
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Joosse M. E.¹,Aardoom M. A.¹,Kemos P.²,Turner D.³,Wilson D. C.⁴,Koletzko S.⁵,Martin-de-Carpi J.⁶,Fagerberg U. L.⁷,Spray C.⁸,Tzivinikos C.⁹,Sladek M.¹⁰,Shaoul R.¹¹,Roma-Giannikou E.¹²,Bronsky J.¹³,Serban D. E.¹⁴,Ruemmele F. M.¹⁵,Garnier-Lengline H.¹⁵,Veres G.¹⁶,Hojsak I.¹⁷,Kolho K. L.¹⁸¹⁹,Davies I. H.²⁰,Aloi M.²¹,Lionetti P.²²,Hussey S.²³,Veereman G.²⁴,Braegger C. P.²⁵,Trindade E.²⁶,Wewer A. V.²⁷,Hauer A. C.²⁸,de Vries A. C. H.¹,Sigall Boneh R.²⁹,Sarbagili Shabat C.²⁹,Levine A.²⁹,de Ridder L.¹^ORCID,

Affiliation:

1. Rotterdam The Netherlands

2. London UK

3. Jerusalem Israel

4. Edinburgh UK

5. Munich Germany

6. Barcelona Spain

7. Stockholm Sweden

8. Bristol UK

9. Dubai United Arab Emirates

10. Cracow Poland

11. Haifa Israel

12. Athens Greece

13. Prague Czech Republic

14. Cluj-Napoca Romania

15. Paris France

16. Budapest Hungary

17. Zagreb Croatia

18. Helsinki Finland

19. Tampere Finland

20. Cardiff UK

21. Rome Italy

22. Florence Italy

23. Dublin Ireland

24. Brussels Belgium

25. Zurich Switzerland

26. Porto Portugal

27. Hvidovre Denmark

28. Graz Austria

29. Tel-Aviv Israel

Funder

ESPGHAN

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14893/fullpdf

Reference32 articles.

1. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease;Limbergen;Gastroenterology,2008

2. Disease behavior in children with Crohn's disease: the effect of disease duration, ethnicity, genotype, and phenotype;Shaoul;Dig Dis Sci,2009

3. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease;Peyrin-Biroulet;Gut,2011

4. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease;Schaik;Gut,2012

5. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project;Cleynen;Gut,2013

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TNF inhibitors as a treatment of pediatric IBD;Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2024-08-20

2. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

3. Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry;The Lancet Child & Adolescent Health;2024-06

4. Medical management of pediatric inflammatory bowel disease;Seminars in Pediatric Surgery;2024-04

5. Rare and Severe Adverse Events in Paediatric Inflammatory Bowel Disease: Results of the International Prospective PIBD-SETQuality Safety Registry;2024